Blocking production of the enzyme JNK1 in cells lining the lungs’ airways protected mice from developing induced idiopathic pulmonary…
Articles by Steve Bryson, PhD
Low daily doses of Esbriet (pirfenidone), less than 1200 mg per day, are equally effective…
No significant differences in survival rates, extending out 10 years, were found in idiopathic pulmonary fibrosis (IPF) patients given…
Simultaneous inhibition of two signaling pathways mediated by TGF-beta1 and periostin can halt progression of idiopathic pulmonary fibrosis…
Genetic screening that can identify variants of the mucin-causing MUC5B gene — the key risk factor that…
Efforts to optimize treatments to address critical challenges in treating idiopathic pulmonary fibrosis (IPF)…
Inflammatory bowel disease (IBD) increases the risk of developing idiopathic…
The natural product tannic acid has anti-fibrotic effects on cultured human lung fibroblasts and in an…
The Pulmonary Fibrosis Foundation (PFF) announced that its nationwide Care Center Network (CCN)…